hormone replacement therapy on menopausal syndrome 36 cases observed（激素替代疗法对绝经期综合征36例）.docVIP

Hormone replacement therapy on menopausal syndrome 36 cases observed 36 cases of menopausal syndrome in estrogen replacement therapy given to three cycles, and improvement of clinical symptoms in clinical observation results show that drug users are more obvious clinical symptoms improved, and achieved good results. In this paper, 36 cases of menopausal syndrome patients given the same dose of estrogen therapy, administration of oral and vaginal administration of sub-ways two ways to choose a voluntary basis by the patient for medication in the treatment system during clinical observation. 1 case selection and administration of 1.1 Case Selection: Choose natural menopause a year over 40 years of clinical examination inadvertent cerebral vascular disease, no diabetes, no abnormal vaginal bleeding, no suspicious breast cancer, endometrial cancer, severe liver disease, gynecological B ultrasonic examination was normal in postmenopausal comprehensive 36 patients with symptoms as a treatment target. 1.2 Delivery Method: Oral administration of a daily oral Premarin tablets 0.625mg, even for 1 - 28 days after treatment 15 - 28 days plus medroxyprogesterone acetate daily service 2.5mg. Vaginal delivery were Daily use Premarin cream 2g, once every 1 - 28 days, after using 15 - 28 days served plus medroxyprogesterone acetate daily 2.5mg. two kinds of treatment methods are continuous medication for 3 cycles. 1.3 Clinical observation: in all cases monthly assessment of clinical symptoms. 2 results 2.1 after treatment, all patients showed significant improvement of menopausal symptoms, but oral administration with systemic symptoms were improved more Obviously, those with vaginal delivery more obvious the improvement of local symptoms (see Table Oral administration were 2.2 in 2 cases of vaginal bleeding 2 weeks after treatment suspension of medication. 2.3 34 cases after 3 cycles of drug urine tests, liver function, blood lipids a